Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Non-Current Debt (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Non-Current Debt for 6 consecutive years, with $460.8 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Non-Current Debt fell 7.43% year-over-year to $460.8 million, compared with a TTM value of $460.8 million through Dec 2024, down 7.43%, and an annual FY2024 reading of $460.8 million, down 7.43% over the prior year.
  • Non-Current Debt was $460.8 million for Q4 2024 at Cresco Labs, down from $497.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $497.7 million in Q4 2023 and bottomed at $255.4 million in Q4 2020.
  • Average Non-Current Debt over 5 years is $431.2 million, with a median of $465.1 million recorded in 2021.
  • The sharpest move saw Non-Current Debt soared 46343.45% in 2020, then fell 7.43% in 2024.
  • Year by year, Non-Current Debt stood at $255.4 million in 2020, then soared by 82.07% to $465.1 million in 2021, then grew by 2.54% to $476.9 million in 2022, then grew by 4.37% to $497.7 million in 2023, then decreased by 7.43% to $460.8 million in 2024.
  • Business Quant data shows Non-Current Debt for CRLBF at $460.8 million in Q4 2024, $497.7 million in Q4 2023, and $476.9 million in Q4 2022.